146 related articles for article (PubMed ID: 3927458)
1. Effect of antirheumatic agents on the mitogen response of arthritic rat spleen cells.
Pasternak RD; Marks RL; Hubbs SJ; DiPasquale G
Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):353-67. PubMed ID: 3927458
[TBL] [Abstract][Full Text] [Related]
2. Lymphoid abnormalities in rats with adjuvant-induced arthritis. I. Mitogen responsiveness and lymphokine synthesis.
Gilman SC; Daniels JF; Wilson RE; Carlson RP; Lewis AJ
Ann Rheum Dis; 1984 Dec; 43(6):847-55. PubMed ID: 6335388
[TBL] [Abstract][Full Text] [Related]
3. Suppressed IL-2 production and response in AA rats: role of suppressor cells and the effect of auranofin treatment.
Lee JC; Rebar L; Demuth S; Hanna N
J Rheumatol; 1985 Oct; 12(5):885-91. PubMed ID: 2935633
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
Kaplan JM; Badger AM; Ruggieri EV; Olivera DL; Newman-Tarr T; Bugelski PJ
J Clin Lab Immunol; 1991 Dec; 36(4):49-58. PubMed ID: 1668843
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models.
Phadke K; Carlson DG; Gitter BD; Butler LD
J Immunol; 1986 Jun; 136(11):4085-91. PubMed ID: 3486226
[TBL] [Abstract][Full Text] [Related]
6. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.
Connolly KM; Stecher VJ; Danis E; Pruden DJ; LaBrie T
Agents Actions; 1988 Aug; 25(1-2):94-105. PubMed ID: 3142230
[TBL] [Abstract][Full Text] [Related]
7. The effect of some antirheumatic drugs in vivo on the response of spleen cells to concanavalin A in rats with chronic inflammation.
Binderup L; Bramm E; Arrigoni-Martelli E
Int J Immunopharmacol; 1982; 4(1):57-66. PubMed ID: 6806203
[TBL] [Abstract][Full Text] [Related]
8. Splenic suppressor cells in adjuvant arthritic rats: effect of D-penicillamine.
Binderup L; Bramm E; Arrigoni-Martelli E
Agents Actions Suppl; 1980; 7():199-203. PubMed ID: 6454335
[TBL] [Abstract][Full Text] [Related]
9. Interleukins production and responsiveness in Fisher rats with adjuvant-induced disease: role of suppressor cells.
Yiangou M; Hadjipetrou-Kourounakis L
J Clin Lab Immunol; 1989 Feb; 28(2):85-90. PubMed ID: 2526223
[TBL] [Abstract][Full Text] [Related]
10. Rat adjuvant arthritis as a model to test potential antirheumatic agents.
Toivonen ML; Tokola O; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1982; 4(6):359-63. PubMed ID: 7144330
[TBL] [Abstract][Full Text] [Related]
11. Restoration of diminished T-cell function in adjuvant induced disease by methotrexate: evidence for two populations of splenic T-cell suppressors.
Kourounakis L; Kapusta MA
J Rheumatol; 1976 Dec; 3(4):346-54. PubMed ID: 1088164
[TBL] [Abstract][Full Text] [Related]
12. Relationship between collagen-induced and adjuvant arthritis in the Lewis rat.
Hunt DW; Corson L; Barker HD; Levy JG; Petty RE
J Autoimmun; 1993 Dec; 6(6):691-700. PubMed ID: 8155251
[TBL] [Abstract][Full Text] [Related]
13. Differences in the injury/sprouting response of splenic noradrenergic nerves in Lewis rats with adjuvant-induced arthritis compared with rats treated with 6-hydroxydopamine.
Lorton D; Lubahn C; Sweeney S; Major A; Lindquist CA; Schaller J; Washington C; Bellinger DL
Brain Behav Immun; 2009 Feb; 23(2):276-85. PubMed ID: 18984038
[TBL] [Abstract][Full Text] [Related]
14. Studies of D-penicillamine (3): immunomodulating effects of D-penicillamine.
Otomo S; Nakaike S; Tsuji I; Mori C; Ohzeki M
Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):313-20. PubMed ID: 6820351
[TBL] [Abstract][Full Text] [Related]
15. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.
Phadke K; Carroll J; Nanda S
Clin Exp Immunol; 1982 Mar; 47(3):579-86. PubMed ID: 6979443
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
17. Difference in preventive effects between the phosphodiesterase iv inhibitor rolipram and anti-arthritic drugs on antigen-induced arthritis in mice.
Yamaki K; Li X; Hossain MA; Alam AH; Taneda S; Yanagisawa R; Takano H; Yoshino S
Immunol Invest; 2007; 36(2):131-45. PubMed ID: 17365015
[TBL] [Abstract][Full Text] [Related]
18. [Effects of slow-acting antirheumatic drugs on blast formation of normal lymphocytes].
Hamai T; Negishi M; Takahashi T
Ryumachi; 1983 Aug; 23(4):193-201. PubMed ID: 6420896
[No Abstract] [Full Text] [Related]
19. Antiarthritic and immunoregulatory activity of spirogermanium.
DiMartino MJ; Lee JC; Badger AM; Muirhead KA; Mirabelli CK; Hanna N
J Pharmacol Exp Ther; 1986 Jan; 236(1):103-10. PubMed ID: 2934544
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant polyarthritis I: incorporation of quantitative measurements of humoral and cellular immune response.
Chang YH
J Pharmacol Exp Ther; 1977 Apr; 201(1):1-7. PubMed ID: 850133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
